Nautilus Biotechnology, Inc. Profile Avatar - Palmy Investing

Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end…

Biotechnology
US, Seattle [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Nautilus Biotechnology, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Nautilus Biotechnology, Inc. can't present revenue by segment

End of NAUT's Analysis
CIK: 1808805 CUSIP: 63909J108 ISIN: US63909J1088 LEI: - UEI: -
Secondary Listings
NAUT has no secondary listings inside our databases.